| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
14,317 |
14,041 |
$808K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,030 |
13,134 |
$678K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,682 |
2,680 |
$430K |
| 93970 |
|
2,832 |
2,825 |
$379K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,259 |
1,258 |
$369K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,882 |
8,231 |
$321K |
| 93925 |
|
2,236 |
2,233 |
$314K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
5,412 |
5,267 |
$283K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,306 |
2,915 |
$226K |
| 36478 |
|
158 |
142 |
$184K |
| 93922 |
|
2,842 |
2,835 |
$174K |
| 93015 |
|
2,084 |
2,054 |
$131K |
| 36247 |
|
107 |
106 |
$120K |
| 93923 |
|
905 |
903 |
$114K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,216 |
1,215 |
$108K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
5,394 |
5,252 |
$93K |
| 93880 |
|
585 |
584 |
$82K |
| 93000 |
|
3,965 |
3,867 |
$46K |
| 99401 |
|
2,759 |
2,541 |
$46K |
| 93224 |
|
495 |
493 |
$38K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
879 |
835 |
$31K |
| 36200 |
|
108 |
106 |
$28K |
| 93229 |
|
48 |
48 |
$26K |
| 75716 |
|
106 |
106 |
$22K |
| 75630 |
|
107 |
107 |
$21K |
| 36140 |
|
108 |
106 |
$20K |
| 93971 |
|
174 |
158 |
$16K |
| 93926 |
|
147 |
146 |
$14K |
| 86769 |
|
375 |
363 |
$14K |
| 99408 |
|
3,469 |
3,034 |
$14K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
207 |
205 |
$14K |
| 99152 |
|
209 |
208 |
$8K |
| 99201 |
|
150 |
150 |
$6K |
| 99441 |
|
325 |
280 |
$6K |
| 94060 |
|
129 |
128 |
$5K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
37 |
37 |
$3K |
| 90674 |
|
190 |
189 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
3,118 |
2,958 |
$3K |
| 94729 |
|
141 |
139 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
233 |
228 |
$2K |
| 94727 |
|
140 |
139 |
$2K |
| 94375 |
|
85 |
85 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
35 |
35 |
$1K |
| 86328 |
|
31 |
31 |
$894.35 |
| 93228 |
|
49 |
49 |
$875.90 |
| 99153 |
Mod sedat endo service >5yrs |
83 |
82 |
$699.68 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
112 |
101 |
$660.00 |
| 81002 |
|
437 |
414 |
$381.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
45 |
43 |
$263.95 |
| 99385 |
|
12 |
12 |
$259.53 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
22 |
22 |
$259.23 |
| 3080F |
|
333 |
309 |
$220.00 |
| 99407 |
|
26 |
25 |
$213.01 |
| 3074F |
|
451 |
400 |
$162.52 |
| 3078F |
|
293 |
260 |
$102.52 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
19 |
19 |
$96.40 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
21 |
21 |
$85.76 |
| 99406 |
|
13 |
13 |
$35.13 |
| 1159F |
|
496 |
422 |
$5.00 |
| 1160F |
|
507 |
428 |
$2.50 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
87 |
79 |
$0.64 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
19 |
18 |
$0.14 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
3,188 |
2,686 |
$0.12 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,481 |
1,284 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
107 |
96 |
$0.00 |
| 93298 |
|
28 |
28 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
42 |
40 |
$0.00 |
| 1011F |
|
20 |
19 |
$0.00 |
| 3077F |
|
76 |
70 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
19 |
19 |
$0.00 |
| 1000F |
|
1,196 |
1,052 |
$0.00 |
| 3079F |
|
126 |
113 |
$0.00 |
| 4086F |
|
48 |
44 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
149 |
130 |
$0.00 |
| 1034F |
|
72 |
61 |
$0.00 |
| 1036F |
|
425 |
361 |
$0.00 |
| 3008F |
|
481 |
427 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
132 |
105 |
$0.00 |
| G0432 |
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening |
101 |
92 |
$0.00 |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
28 |
28 |
$0.00 |
| 99000 |
|
179 |
178 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
14 |
14 |
$0.00 |
| 3075F |
|
34 |
32 |
$0.00 |
| G0202 |
Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed |
26 |
25 |
$0.00 |